Ursodiol 500 MG

DRUG3 trials

Sponsors

Daewoong Pharmaceutical Co. LTD., Medical College of Wisconsin

Conditions

Clostridioides Difficile InfectionHealthy

Early Phase 1

Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy

Not yet recruitingNCT06884748

Medical College of WisconsinClostridioides Difficile Infection

Start: 2026-05-01End: 2028-05-01Target: 30Updated: 2026-04-29

Phase 1

A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fasting Conditions

CompletedNCT03512808

Daewoong Pharmaceutical Co. LTD.Healthy

Start: 2017-06-01End: 2017-07-31Updated: 2018-05-07

A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fed Conditions

CompletedNCT03512821

Daewoong Pharmaceutical Co. LTD.Healthy

Start: 2017-10-01End: 2017-11-30Updated: 2018-05-07